Drug Trial Radar · NCT04976855
Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder
Last checked: Nov 19, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Aug 17, 2022
Primary completion
Jul 5, 2023
Study completion Jul 5, 2023
Sponsor
- Lead sponsor
- Indivior Inc.Industry
- Sponsor type
- Industry
- Collaborators
- National Institute on Drug Abuse (NIDA)
- First posted
- Jul 26, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objectives for the study are: * Part I and Part II: Assess safety and tolerability of repeated doses of INDV-2000 in healthy volunteers. * Part III: Assess the safety and tolerability of repeated doses of INDV-2000 administered alone and with SUBOXONE sublingual (SL) film in an opioid use disorder (OUD) treatment seeking population.
Conditions
- Healthy Volunteer
- Opioid-use Disorder
Interventions
INDV-2000Drug
Capsule for oral administration
PlaceboDrug
Capsule for oral administration
SUBOXONE® sublingual filmDrug
Administered either under the tongue (sublingual) or between the gum and cheek (buccal)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part I and Part II: Number of Participants With Adverse EventsTime frame: From first dose of study drug up to 7 days after last dose (up to 14 days in Part I and 35 days in Part II).
- Part III: Number of Participants With Adverse EventsTime frame: From first dose of INDV-2000 up to 7 days after last dose (up to 18 days).
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Johns Hopkins University School of Medicine BPRU
Baltimore, Maryland
InSite Clinical Research
DeSoto, Texas
Worldwide Clinical Trials
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.